(State or Other Jurisdiction of Incorporation) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||
Page No. | ||
Condensed Consolidated Balance Sheets — March 31, 2024 and December 31, 2023 | ||
Condensed Consolidated Statements of Operations — Three Months Ended March 31, 2024 and 2023 | ||
Condensed Consolidated Statements of Comprehensive Loss — Three Months Ended March 31, 2024 and 2023 | ||
Condensed Consolidated Statements of Stockholders’ Equity — Three Months Ended March 31, 2024 and 2023 | ||
Condensed Consolidated Statements of Cash Flows — Three Months Ended March 31, 2024 and 2023 | ||
•our belief that our PX offers market-leading value with the highest technological and economic benefit; |
•our belief that leveraging our pressure exchanger technology will unlock new commercial opportunities in the future; |
•our belief that our PX G1300™ can contribute to help make CO2-based refrigeration economically viable in a broader range of climates; |
•our belief that our technology helps our customer achieve environmentally sustainable operations; |
•our expectation that sales outside of the U.S. will remain a significant portion of our revenue; |
•the scale of the environmental impact from the use of our solutions; |
•our belief that our sustainability goals are highly influential to our business success; |
•the timing of our receipt of payment for products or services from our customers; |
•our belief that our existing cash and cash equivalents, our short and/or long-term investments, and the ongoing cash generated from our operations, will be sufficient to meet our anticipated liquidity needs for the foreseeable future, with the exception of a decision to enter into an acquisition and/or fund investments in our latest technology arising from rapid market adoption that could require us to seek additional equity or debt financing; |
•our expectations relating to the amount and timing of recognized revenue from our projects; |
•our expectations relating to expenses; |
•our expectation that we will continue to receive a tax benefit related to U.S. federal foreign-derived intangible income and California research and development tax credit; |
•the outcome of proceedings, lawsuits, disputes and claims; |
•the impact of losses due to indemnification obligations; |
•other factors disclosed under the MD&A and Part I, Item 3, “Quantitative and Qualitative Disclosures about Market Risk,” and elsewhere in this Form 10-Q. |
March 31, 2024 | December 31, 2023 | ||
(In thousands) | |||
ASSETS | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Short-term investments | |||
Accounts receivable, net | |||
Inventories, net | |||
Prepaid expenses and other assets | |||
Total current assets | |||
Long-term investments | |||
Deferred tax assets, net | |||
Property and equipment, net | |||
Operating lease, right of use asset | |||
Goodwill | |||
Other assets, non-current | |||
Total assets | $ | $ | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Accrued expenses and other liabilities | |||
Lease liabilities | |||
Contract liabilities | |||
Total current liabilities | |||
Lease liabilities, non-current | |||
Other liabilities, non-current | |||
Total liabilities | |||
Commitments and contingencies (Note 7) | |||
Stockholders’ equity: | |||
Common stock | |||
Additional paid-in capital | |||
Accumulated other comprehensive loss | ( | ( | |
Treasury stock | ( | ( | |
Retained earnings | |||
Total stockholders’ equity | |||
Total liabilities and stockholders’ equity | $ | $ |
Three Months Ended March 31, | |||
2024 | 2023 | ||
(In thousands, except per share data) | |||
Revenue | $ | $ | |
Cost of revenue | |||
Gross profit | |||
Operating expenses: | |||
General and administrative | |||
Sales and marketing | |||
Research and development | |||
Total operating expenses | |||
Loss from operations | ( | ( | |
Other income (expense): | |||
Interest income | |||
Other non-operating income (expense), net | ( | ||
Total other income, net | |||
Loss before income taxes | ( | ( | |
Benefit from income taxes | ( | ( | |
Net loss | $( | $( | |
Net loss per share: | |||
Basic | $ ( | $ ( | |
Diluted | $ ( | $ ( | |
Number of shares used in per share calculations: | |||
Basic | |||
Diluted |
Three Months Ended March 31, | |||
2024 | 2023 | ||
(In thousands) | |||
Net loss | $( | $( | |
Other comprehensive income (loss), net of tax | |||
Foreign currency translation adjustments | ( | ||
Unrealized gain (loss) on investments | ( | ||
Total other comprehensive income (loss), net of tax | ( | ||
Comprehensive loss | $( | $( |
Three Months Ended March 31, | |||
2024 | 2023 | ||
(In thousands, except shares) | |||
Common stock | |||
Beginning and ending balance | $ | $ | |
Additional paid-in capital | |||
Beginning balance | |||
Issuance of common stock, net | |||
Stock-based compensation | |||
Ending balance | |||
Accumulated other comprehensive loss | |||
Beginning balance | ( | ( | |
Other comprehensive (loss) income | |||
Foreign currency translation adjustments | ( | ||
Unrealized (loss) gain on investments | ( | ||
Total other comprehensive (loss) income, net | ( | ||
Ending balance | ( | ( | |
Treasury stock | |||
Beginning and ending balance | ( | ( | |
Retained earnings | |||
Beginning balance | |||
Net loss | ( | ( | |
Ending balance | |||
Total stockholders’ equity | $ | $ | |
Common stock issued (shares) | |||
Beginning balance | |||
Issuance of common stock, net | |||
Ending balance | |||
Treasury stock (shares) | |||
Beginning and ending balance | |||
Total common stock outstanding (shares) |
Three Months Ended March 31, | |||
2024 | 2023 | ||
(In thousands) | |||
Cash flows from operating activities: | |||
Net loss | $( | $( | |
Adjustments to reconcile net loss to cash provided by operating activities | |||
Stock-based compensation | |||
Depreciation and amortization | |||
Right of use asset amortization | |||
Accretion (amortization) of discounts (premiums) on investments | ( | ( | |
Deferred income taxes | ( | ( | |
Other non-cash adjustments | |||
Changes in operating assets and liabilities: | |||
Accounts receivable, net | |||
Contract assets | |||
Inventories, net | ( | ( | |
Prepaid and other assets | ( | ||
Accounts payable | |||
Accrued expenses and other liabilities | ( | ( | |
Contract liabilities | |||
Net cash provided by operating activities | |||
Cash flows from investing activities: | |||
Maturities of marketable securities | |||
Purchases of marketable securities | ( | ( | |
Capital expenditures | ( | ( | |
Proceeds from sales of fixed assets | |||
Net cash (used in) provided by investing activities | ( | ||
Cash flows from financing activities: | |||
Net proceeds from issuance of common stock | |||
Net cash provided by financing activities | |||
Effect of exchange rate differences on cash and cash equivalents | ( | ||
Net change in cash, cash equivalents and restricted cash | |||
Cash, cash equivalents and restricted cash, beginning of year | |||
Cash, cash equivalents and restricted cash, end of period | $ | $ |
Three Months Ended March 31, 2024 | Three Months Ended March 31, 2023 | ||||||||||
Water | Emerging Technologies | Total | Water | Emerging Technologies | Total | ||||||
(In thousands) | |||||||||||
Geographical market | |||||||||||
Middle East and Africa | $ | $ | $ | $ | $ | $ | |||||
Americas | |||||||||||
Asia | |||||||||||
Europe | |||||||||||
Total revenue | $ | $ | $ | $ | $ | $ | |||||
Channel | |||||||||||
Aftermarket | $ | $ | $ | $ | $ | $ | |||||
Megaproject | |||||||||||
Original equipment manufacturer | |||||||||||
Total revenue | $ | $ | $ | $ | $ | $ |
March 31, 2024 | December 31, 2023 | ||
(In thousands) | |||
Accounts receivable, net | $ | $ | |
Contract assets, current (included in prepaid expenses and other assets) | |||
Contract liabilities: | |||
Contract liabilities, current | $ | $ | |
Contract liabilities, non-current (included in other liabilities, non-current) | |||
Total contract liabilities | $ | $ |
March 31, 2024 | December 31, 2023 | ||
(In thousands) | |||
Contract liabilities, beginning of year | $ | $ | |
Revenue recognized | ( | ( | |
Cash received, excluding amounts recognized as revenue during the period | |||
Contract liabilities, end of period | $ | $ |
Period | Remaining Performance Obligations | |
(In thousands) | ||
2024 (remaining nine months) | $ | |
2025 |
Three Months Ended March 31, | |||
2024 | 2023 | ||
(In thousands, except per share amounts) | |||
Numerator | |||
Net loss | $( | $( | |
Denominator (weighted average shares) | |||
Basic and dilutive common shares outstanding | |||
Net loss per share | |||
Basic | $ ( | $ ( | |
Diluted | $ ( | $ ( |
Three Months Ended March 31, | |||
2024 | 2023 | ||
(In thousands) | |||
Anti-dilutive equity award shares | |||
March 31, 2024 | December 31, 2023 | March 31, 2023 | |||
(In thousands) | |||||
Cash and cash equivalents | $ | $ | $ | ||
Restricted cash, non-current (included in other assets, non-current) | |||||
Total cash, cash equivalents and restricted cash | $ | $ | $ |
March 31, 2024 | December 31, 2023 | ||
(In thousands) | |||
Accounts receivable, gross | $ | $ | |
Allowance for doubtful accounts | ( | ( | |
Accounts receivable, net | $ | $ |
March 31, 2024 | December 31, 2023 | ||
(In thousands) | |||
Raw materials | $ | $ | |
Work in process | |||
Finished goods | |||
Inventories, gross | |||
Valuation adjustments for excess and obsolete inventory | ( | ( | |
Inventories, net | $ | $ |
March 31, 2024 | December 31, 2023 | ||
(In thousands) | |||
Current | |||
Payroll, incentives and commissions payable | $ | $ | |
Warranty reserve | |||
Income taxes payable | |||
Other accrued expenses and other liabilities | |||
Total accrued expenses and other liabilities | |||
Other liabilities, non-current | |||
Total accrued expenses, and current and non-current other liabilities | $ | $ |
March 31, 2024 | December 31, 2023 | ||||||||||||||||
Pricing Category | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||
(In thousands) | |||||||||||||||||
Cash equivalents | |||||||||||||||||
Money market securities | Level 1 | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||
Short-term investments | |||||||||||||||||
U.S. treasury securities | Level 2 | ( | ( | ||||||||||||||
Corporate notes and bonds | Level 2 | ( | ( | ||||||||||||||
Municipal and agency notes and bonds | Level 2 | ( | ( | ||||||||||||||
Total short-term investments | ( | ( | |||||||||||||||
Long-term investments | |||||||||||||||||
Corporate notes and bonds | Level 2 | ( | ( | ||||||||||||||
Municipal and agency notes and bonds | Level 2 | ( | ( | ||||||||||||||
Total long-term investments | ( | ( | |||||||||||||||
Total short and long-term investments | ( | ( | |||||||||||||||
Total | $ | $ | $( | $ | $ | $ | $( | $ |
March 31, 2024 | December 31, 2023 | ||||||
Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | ||||
(In thousands) | |||||||
U.S. treasury securities | $ | $( | $ | $( | |||
Corporate notes and bonds | ( | ( | |||||
Municipal and agency notes and bonds | ( | ( | |||||
Total available-for-sale investments with unrealized loss positions | $ | $( | $ | $( |
March 31, 2024 | December 31, 2023 | ||
(In thousands) | |||
Outstanding letters of credit | $ | $ |
Three Months Ended March 31, | |||
2024 | 2023 | ||
(In thousands, except percentages) | |||
Benefit from income taxes | $( | $( | |
Discrete items | |||
Benefit from income taxes, excluding discrete items | $( | $( | |
Effective tax rate | |||
Effective tax rate, excluding discrete items |
Three Months Ended March 31, | |||||||||||
2024 | 2023 | ||||||||||
Water | Emerging Technologies | Total | Water | Emerging Technologies | Total | ||||||
(In thousands) | |||||||||||
Revenue | $ | $ | $ | $ | $ | $ | |||||
Cost of revenue | |||||||||||
Gross profit (loss) | ( | ||||||||||
Operating expenses | |||||||||||
General and administrative | |||||||||||
Sales and marketing | |||||||||||
Research and development | |||||||||||
Total operating expenses | |||||||||||
Operating income (loss) | $ | $( | ( | $ | $( | ( | |||||
Less: Corporate operating expenses | |||||||||||
Loss from operations | $( | $( |
Three Months Ended March 31, | |||||
Segment | 2024 | 2023 | |||
Customer A | Water | ** | |||
Customer B | Water | ** | |||
Customer C | Water | ** | |||
Customer D | Water | ** |
Three Months Ended March 31, | |||||||||||
2024 | 2023 | ||||||||||
Revenue | % of Revenue | Revenue | % of Revenue | Change | |||||||
(In thousands, except percentages) | |||||||||||
Aftermarket | $4,644 | 38% | $3,322 | 25% | $1,322 | 40% | |||||
Megaproject | 4,100 | 34% | 3,243 | 24% | 857 | 26% | |||||
Original equipment manufacturer | 3,346 | 28% | 6,836 | 51% | (3,490) | (51%) | |||||
Total revenue | $12,090 | 100% | $13,401 | 100% | $(1,311) | (10%) |
Three Months Ended March 31, | |||||||||||
2024 | 2023 | ||||||||||
Water | Emerging Technologies | Total | Water | Emerging Technologies | Total | ||||||
(In thousands) | |||||||||||
Middle East and Africa | $4,785 | $1 | $4,786 | $2,739 | $— | $2,739 | |||||
Americas | 3,939 | — | 3,939 | 3,208 | 30 | 3,238 | |||||
Asia | 1,979 | — | 1,979 | 6,114 | — | 6,114 | |||||
Europe | 1,386 | — | 1,386 | 1,235 | 75 | 1,310 | |||||
Total revenue | $12,089 | $1 | $12,090 | $13,296 | $105 | $13,401 |
Three Months Ended March 31, | |||||||||||
2024 | 2023 | ||||||||||
Gross Profit | Gross Margin % | Gross Profit | Gross Margin % | Change in Gross Profit | |||||||
(In thousands, except percentages) | |||||||||||
Gross profit and gross margin | $7,135 | 59.0% | $8,155 | 60.9% | $(1,020) | (12.5%) |
Three Months Ended March 31, | |||||||||||||||
2024 | 2023 | ||||||||||||||
Water | Emerging Technologies | Corporate | Total | Water | Emerging Technologies | Corporate | Total | ||||||||
(In thousands) | |||||||||||||||
General and administrative | $1,922 | $1,018 | $4,626 | $7,566 | $1,938 | $968 | $4,160 | $7,066 | |||||||
Sales and marketing | 3,745 | 1,807 | 600 | 6,152 | 3,175 | 1,170 | 549 | 4,894 | |||||||
Research and development | 1,100 | 3,251 | — | 4,351 | 1,180 | 3,126 | — | 4,306 | |||||||
Total operating expenses | $6,767 | $6,076 | $5,226 | $18,069 | $6,293 | $5,264 | $4,709 | $16,266 |
Three Months Ended March 31, | |||
2024 | 2023 | ||
(In thousands) | |||
Interest income | $1,442 | $621 | |
Other non-operating (expense) income, net | (53) | 35 | |
Total other income, net | $1,389 | $656 |
Three Months Ended March 31, | |||
2024 | 2023 | ||
(In thousands, except percentages) | |||
Benefit from income taxes | $(1,285) | $(1,159) | |
Discrete items | 76 | 488 | |
Benefit from income taxes, excluding discrete items | $(1,209) | $(671) | |
Effective tax rate | 13.5% | 15.5% | |
Effective tax rate, excluding discrete items | 12.7% | 9.0% |
Three Months Ended March 31, | |||||
2024 | 2023 | Change | |||
(In thousands) | |||||
Net cash provided by operating activities | $6,497 | $8,657 | $(2,160) | ||
Net cash (used in) provided by investing activities | (4,986) | 1,167 | (6,153) | ||
Net cash provided by financing activities | 1,190 | 165 | 1,025 | ||
Effect of exchange rate differences on cash and cash equivalents | (19) | 8 | (27) | ||
Net change in cash, cash equivalents and restricted cash | $2,682 | $9,997 | $(7,315) |
Name | Title | Date of Adoption or Termination (1) | Status (2) | Plan Type | ||||
Rule 10b5-1 trading arrangement (3) | ||||||||
Rule 10b5-1 trading arrangement (4) |
Exhibit Number | Exhibit Description | Incorporated by Reference | ||||||||
Form | File No. | Exhibit | Filing Date | |||||||
8-K/A | 001-34112 | 10.1 | 1/31/2024 | |||||||
31.1* | ||||||||||
31.2* | ||||||||||
32.1** | ||||||||||
101 | Inline XBRL Document Set for the consolidated financial statements and accompanying notes in Part I, “Financial Information” of this Quarterly Report on Form 10-Q. | |||||||||
104 | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set. |
ENERGY RECOVERY, INC. | |||||
Date: | May 1, 2024 | By: | /s/ DAVID W. MOON | ||
David W. Moon | |||||
President and Chief Executive Officer | |||||
(Principal Executive Officer) | |||||
Date: | May 1, 2024 | By: | /s/ JOSHUA BALLARD | ||
Joshua Ballard | |||||
Chief Financial Officer | |||||
(Principal Financial and Accounting Officer) |